Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 1.3M | 911,553 | 655,358 | 548,861 | 667,482 |
| General And Administrative Expense | 1.0M | 795,961 | 520,185 | 386,462 | 529,445 |
| Other Operating Expenses | 6.6M | 6.8M | 378,514 | 623,933 | 1.3M |
| Operating Expense | 7.9M | 7.7M | 1.0M | 1.2M | 2.0M |
| Operating Income | -7.9M | -7.7M | -1.0M | -1.2M | -2.0M |
| EBIT | -7.9M | -7.7M | -1.0M | -1.2M | -2.0M |
| Interest Income | 54,657 | 38,392 | 34,786 | 123,172 | 66,911 |
| Interest Income Non Operating | 54,657 | 38,392 | 34,786 | 123,172 | 66,911 |
| Net Interest Income | 54,657 | 38,392 | 34,786 | 123,172 | 66,911 |
| Other Income Expense | 421,096 | -- | -- | -- | -- |
| Other Non Operating Income Expenses | 421,096 | -- | -- | -- | -- |
| Special Income Charges | -- | -- | -- | -- | -- |
| Pretax Income | -7.4M | -7.0M | -999,086 | -1.0M | -1.9M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -7.4M | -7.0M | -999,086 | -1.0M | -1.9M |
| Net Income From Continuing Operation Net Minority Interest | -7.4M | -7.0M | -999,086 | -1.0M | -1.9M |
| Net Income Including Noncontrolling Interests | -7.4M | -7.0M | -999,086 | -1.0M | -1.9M |
| Net Income Common Stockholders | -7.4M | -7.0M | -999,086 | -1.0M | -1.9M |
| Net Income | -7.4M | -7.0M | -999,086 | -1.0M | -1.9M |
| EBITDA | -7.9M | -7.7M | -1.0M | -1.2M | -2.0M |
| Normalized EBITDA | -7.9M | -7.7M | -1.0M | -1.2M | -2.0M |
| Reconciled Depreciation | 28,039 | 26,759 | 21,076 | 15,328 | 15,626 |
| Basic EPS | -0.12 | -- | -0.02 | -0.02 | -0.04 |
| Diluted EPS | -0.12 | -- | -0.02 | -0.02 | -0.04 |
| Basic Average Shares | 63.7M | -- | 50.0M | 50.0M | 50.0M |
| Diluted Average Shares | 63.7M | -- | 50.0M | 50.0M | 50.0M |
| Total Unusual Items | -- | -- | -- | -- | -- |
| Total Unusual Items Excluding Goodwill | -- | -- | -- | -- | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -7.4M | -7.0M | -999,086 | -1.0M | -1.9M |
| Diluted NI Availto Com Stockholders | -7.4M | -7.0M | -999,086 | -1.0M | -1.9M |
| Gain On Sale Of Ppe | -- | -- | -- | -- | -- |
| Net Income Continuous Operations | -7.4M | -7.0M | -999,086 | -1.0M | -1.9M |
| Net Non Operating Interest Income Expense | 54,657 | 38,392 | 34,786 | 123,172 | 66,911 |
| Other Gand A | 793,890 | 491,797 | 342,830 | 287,141 | 256,368 |
| Salaries And Wages | 210,234 | 304,164 | 177,355 | 99,321 | 273,077 |
| Selling And Marketing Expense | 277,365 | 115,592 | 135,173 | 162,399 | 138,037 |
| Total Expenses | 7.9M | 7.7M | 1.0M | 1.2M | 2.0M |
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 10.1M | 13.2M | 5.5M | 6.4M | 6.2M |
| Cash Cash Equivalents And Short Term Investments | 10.1M | 13.2M | 5.5M | 6.4M | 6.2M |
| Cash Financial | 10.1M | 13.2M | -- | -- | -- |
| Accounts Receivable | 0.00 | 5,281 | 5,281 | 5,281 | 5,281 |
| Receivables | 384,448 | 361,012 | 37,643 | 114,589 | 1.3M |
| Prepaid Assets | 361,547 | 119,197 | 87,006 | 111,155 | 195,005 |
| Current Assets | 10.9M | 13.6M | 5.6M | 6.6M | 7.7M |
| Gross PPE | 1.1M | 1.1M | 1.1M | 920,758 | 920,758 |
| Accumulated Depreciation | -354,415 | -326,376 | -299,617 | -278,541 | -263,213 |
| Net PPE | 765,138 | 793,177 | 790,121 | 642,217 | 657,545 |
| Other Non Current Assets | 291,635 | 291,635 | 271,435 | 261,432 | -- |
| Total Non Current Assets | 1.1M | 1.1M | 1.1M | 903,649 | 905,977 |
| Total Assets | 11.9M | 14.7M | 6.7M | 7.5M | 8.6M |
| Accounts Payable | 1.5M | 3.0M | 74,826 | 190,305 | 201,971 |
| Payables | 1.8M | 3.1M | 117,535 | 218,390 | 259,502 |
| Payables And Accrued Expenses | 2.1M | 4.1M | 228,735 | 271,964 | 383,700 |
| Current Accrued Expenses | 301,322 | 1.0M | 111,200 | 53,574 | 124,198 |
| Other Current Liabilities | -- | 421,096 | -- | -- | -- |
| Current Liabilities | 2.1M | 4.5M | 228,735 | 271,964 | 383,700 |
| Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 2.1M | 4.5M | 228,735 | 271,964 | 383,700 |
| Common Stock | 66.4M | 62.1M | 51.8M | 51.8M | 51.8M |
| Capital Stock | 66.4M | 62.1M | 51.8M | 51.8M | 51.8M |
| Additional Paid In Capital | 2.6M | -- | -- | -- | 7.1M |
| Retained Earnings | -67.1M | -59.7M | -52.7M | -51.7M | -50.7M |
| Gains Losses Not Affecting Retained Earnings | 8.0M | 7.8M | 7.4M | 7.2M | -- |
| Other Equity Adjustments | 8.0M | 7.8M | 7.4M | 7.2M | -- |
| Common Stock Equity | 9.8M | 10.2M | 6.4M | 7.3M | 8.2M |
| Stockholders Equity | 9.8M | 10.2M | 6.4M | 7.3M | 8.2M |
| Total Equity Gross Minority Interest | 9.8M | 10.2M | 6.4M | 7.3M | 8.2M |
| Total Capitalization | 9.8M | 10.2M | 6.4M | 7.3M | 8.2M |
| Net Tangible Assets | 9.8M | 10.2M | 6.4M | 7.3M | 8.2M |
| Tangible Book Value | 9.8M | 10.2M | 6.4M | 7.3M | 8.2M |
| Working Capital | 8.7M | 9.1M | 5.4M | 6.4M | 7.3M |
| Invested Capital | 9.8M | 10.2M | 6.4M | 7.3M | 8.2M |
| Share Issued | 64.2M | 60.5M | 50.0M | 50.0M | 299.8M |
| Ordinary Shares Number | 64.2M | 60.5M | 50.0M | 50.0M | 299.8M |
| Buildings And Improvements | 541,478 | 541,478 | 541,478 | 541,478 | 541,478 |
| Dueto Related Parties Current | 317,934 | 82,965 | 42,709 | 28,085 | 57,531 |
| Land And Improvements | 137,594 | 137,594 | 137,594 | 137,594 | 137,594 |
| Machinery Furniture Equipment | 291,199 | 291,199 | 277,091 | 177,683 | 177,683 |
| Non Current Deferred Assets | 13,023 | -- | -- | -- | -- |
| Non Current Prepaid Assets | -- | -- | -- | -- | 248,432 |
| Other Properties | 149,282 | 149,282 | 133,575 | 64,003 | 64,003 |
| Taxes Receivable | 384,448 | 355,731 | 32,362 | 109,308 | 1.3M |
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -9.9M | -3.8M | -742,789 | 244,949 | -3.1M |
| Cash Flow From Continuing Operating Activities | -9.9M | -3.8M | -742,789 | 244,949 | -3.1M |
| Depreciation And Amortization | 28,039 | 26,759 | 21,076 | 15,328 | 15,626 |
| Depreciation Amortization Depletion | 28,039 | 26,759 | 21,076 | 15,328 | 15,626 |
| Stock Based Compensation | 210,234 | 304,164 | 177,355 | 99,321 | 273,077 |
| Change In Working Capital | -2.3M | 3.5M | 57,866 | 1.2M | -1.5M |
| Change In Receivables | -23,436 | -323,369 | 76,946 | 1.2M | 63,622 |
| Change In Payables And Accrued Expense | -2.0M | 3.8M | -43,229 | -111,736 | -1.6M |
| Other Non Cash Items | -421,096 | -- | -- | -- | -- |
| Capital Expenditure | -- | -29,815 | -168,980 | -- | -1,960 |
| Purchase Of PPE | 0.00 | -29,815 | -168,980 | 0.00 | -1,960 |
| Net PPE Purchase And Sale | 0.00 | -29,815 | -168,980 | 0.00 | -1,960 |
| Investing Cash Flow | 0.00 | -50,015 | -178,983 | -13,000 | -1,960 |
| Cash Flow From Continuing Investing Activities | 0.00 | -50,015 | -178,983 | -13,000 | -1,960 |
| Issuance Of Capital Stock | 4.5M | 11.7M | 0.00 | 0.00 | 0.00 |
| Net Common Stock Issuance | 4.5M | 11.7M | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 6.8M | 11.6M | 0.00 | 0.00 | 0.00 |
| Cash Flow From Continuing Financing Activities | 6.8M | 11.6M | 0.00 | 0.00 | 0.00 |
| Changes In Cash | -3.0M | 7.7M | -921,772 | 231,949 | -3.1M |
| Beginning Cash Position | 13.2M | 5.5M | 6.4M | 6.2M | 9.3M |
| End Cash Position | 10.1M | 13.2M | 5.5M | 6.4M | 6.2M |
| Free Cash Flow | -9.9M | -3.9M | -911,769 | 244,949 | -3.1M |
| Amortization Cash Flow | 28,039 | -- | -- | -- | 15,626 |
| Amortization Of Intangibles | 28,039 | -- | -- | -- | 15,626 |
| Change In Prepaid Assets | -242,350 | -32,191 | 24,149 | 83,850 | 9,945 |
| Common Stock Issuance | 4.5M | 11.7M | 0.00 | 0.00 | 0.00 |
| Depreciation | -- | -- | -- | 15,328 | 15,626 |
| Gain Loss On Sale Of PPE | -- | 0.00 | -- | -- | -- |
| Net Income From Continuing Operations | -7.4M | -7.0M | -999,086 | -1.1M | -1.9M |
| Net Other Financing Charges | 2.3M | -- | -- | -- | -- |
| Net Other Investing Changes | -- | -20,200 | -10,003 | -- | -- |
| Operating Gains Losses | -- | -- | -- | -- | -- |
| Proceeds From Stock Option Exercised | 54,302 | -- | -- | -- | 0.00 |
| Sale Of PPE | -- | 0.00 | -- | -- | -- |